These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35268362)

  • 1. A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires.
    van Leeuwaarde RS; González-Clavijo AM; Pracht M; Emelianova G; Cheung WY; Thirlwell C; Öberg K; Spada F
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary Thyroid Cancer Patient's Assessment of Quality of Life Tools: Results from the QaLM Study.
    Moss L; Cox C; Wadsley J; Newbold K; Strachan MWJ; Druce M; Tolley N; Graham K; Jefferies S; Fresco L; Sivabalasingham S; Balfour A; Hurt C
    Eur Thyroid J; 2021 Mar; 10(1):72-78. PubMed ID: 33777822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
    Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA
    J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS).
    Benavent M; Sastre J; Escobar IG; Segura A; Capdevila J; Carmona A; Sevilla I; Alonso T; Crespo G; García L; Canal N; de la Cruz G; Gallego J
    Health Qual Life Outcomes; 2021 Jan; 19(1):38. PubMed ID: 33516211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the acceptability, reliability, and validity of the EORTC Quality of Life Questionnaire (QLQ-C30) in Kenyan cancer patients: a cross-sectional study.
    Davda J; Kibet H; Achieng E; Atundo L; Komen T
    J Patient Rep Outcomes; 2021 Jan; 5(1):4. PubMed ID: 33415528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours.
    Yadegarfar G; Friend L; Jones L; Plum LM; Ardill J; Taal B; Larsson G; Jeziorski K; Kwekkeboom D; Ramage JK;
    Br J Cancer; 2013 Feb; 108(2):301-10. PubMed ID: 23322194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer.
    Bedard G; Zeng L; Zhang L; Lauzon N; Holden L; Tsao M; Danjoux C; Barnes E; Sahgal A; Poon M; Chow E
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):109-17. PubMed ID: 23551530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
    Bedard G; Zeng L; Poon M; Lam H; Lauzon N; Chow E
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):118-23. PubMed ID: 23551978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
    Hagiwara Y; Shiroiwa T; Taira N; Kawahara T; Konomura K; Noto S; Fukuda T; Shimozuma K
    Health Qual Life Outcomes; 2020 Nov; 18(1):354. PubMed ID: 33143687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore.
    Tan ML; Idris DB; Teo LW; Loh SY; Seow GC; Chia YY; Tin AS
    Asia Pac J Oncol Nurs; 2014; 1(1):22-32. PubMed ID: 27981079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational Study to Assess Quality of Life in Patients with Pancreatic Neuroendocrine Tumors Receiving Treatment with Everolimus: The OBLIQUE Study (UK Phase IV Trial).
    Ramage JK; Punia P; Faluyi O; Frilling A; Meyer T; Saharan R; Valle JW
    Neuroendocrinology; 2019; 108(4):317-327. PubMed ID: 30699423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.
    Apolone G; Filiberti A; Cifani S; Ruggiata R; Mosconi P
    Ann Oncol; 1998 May; 9(5):549-57. PubMed ID: 9653497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia.
    Ayana BA; Negash S; Yusuf L; Tigeneh W; Haile D
    PLoS One; 2016; 11(6):e0157359. PubMed ID: 27304066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.
    Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
    BMC Palliat Care; 2020 Jun; 19(1):81. PubMed ID: 32517678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.